We're conducting a clinical study evaluating an investigational drug (avacopan) designed to potentially target the source of moderate to severe hidradenitis suppurativa, or acne inversa - with the hope of contributing to new scientific discovery.SEE IF YOU PREQUALIFY
Hidradenitis suppurativa, or acne inversa, can start off as small bumps or pimples in areas like your armpit or groin. As this skin disease becomes more severe, these bumps grow deeper, become painful, and can rupture or leak. That's why the Aurora Study is being conducted. It's evaluating an investigational drug (avacopan) designed to potentially target the source of this painful condition.
Study participation will last 44 weeks, and all eligible
participants will receive the following at no cost:
If you are living with hidradenitis suppurativa and are looking for a different way to manage this painful condition, consider participating in the Aurora Study. To see if you prequalify, please take this brief questionnaire.